Unicycive Therapeutics, Inc. (UNCY) stock
UNCYNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.57−0.13 (-3.51%)
Close on Nov 18, 2026Market cap $99.44MP/E –Yield –
Unicycive Therapeutics price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Unicycive Therapeutics's price to sales ratio was 57.7× on Apr 30, 2024.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2024 | Apr 30, 2024 | 57.7× | +13.0 |
| 2023 | Dec 29, 2023 | 44.7× | – |
See a number that looks wrong?